Document Detail


Reduction in adverse effects of mechanical ventilation in rabbits with acute respiratory failure by treatment with extracorporeal CO2 removal and a large fluid volume of diluted surfactant.
MedLine Citation:
PMID:  9386843     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The long-term outcome of infants with severe respiratory distress syndrome can be improved by optimizing surfactant therapy and minimizing the risk for pulmonary barovolutrauma and oxygen toxicity. The authors hypothesized that this may be achieved with low frequency ventilation and extracorporeal CO2 removal (LFV-ECCO2R), in combination with intratracheal instillation of a large fluid volume with diluted surfactant. Lung lavaged rabbits were initially ventilated with continuous positive pressure ventilation. The rabbits were randomized to treatment with LFV-ECCO2R and surfactant (experimental group), or surfactant only (control group). In the experimental group, the rabbits were treated with a large volume (16 ml/kg) of diluted surfactant (6.25 mg/ml) at a dose of 100 mg/kg body weight. After surfactant therapy, the FiO2 100% was gradually decreased. During 4 hours, the extracorporeal bloodflow was adjusted to maintain the PaCO2 between 4.0-6.0 kPa. Thereafter, the rabbits were allowed to breathe spontaneously with 2.5 cm H2O continuous positive airway pressure ventilation (CPAP) and 40% oxygen. In the control group, the rabbits received the same surfactant therapy. During the study period, the rabbits remained ventilated with an inspiratory oxygen concentration (FiO2) of 100% for 4 hours. The ventilator flow was adjusted to maintain the PaCO2 between 4.0 and 6.0 kPa. Thereafter, positive-end expiratory pressure was decreased to 2.5 cm H2O and FiO2 was gradually decreased to 40%. In the experimental group, FiO2 was decreased to 40% in a stepwise fashion whereby the PaO2 could be maintained easily within the normal range. Extracorporeal flow rates during perfusion ranged from 20-35 ml/kg/min and were sufficient to keep the PaCO2 and pH within normal limits. After 4 hours, the rabbits could breathe spontaneously with CPAP and 40% oxygen, while normal blood gas values were maintained. All rabbits survived the experiment. In the control group, all rabbits experienced severe hypoxemia, despite FiO2 of 100% oxygen and, during the course of weaning, all rabbits died because of hypoxia. In conclusion, the present study demonstrated that barovolutrauma due to mechanical ventilation, and oxygen toxicity due to high FiO2, can be minimized in an animal model of acute respiratory failure by the combination of LFV-ECCO2R and surfactant therapy.
Authors:
F B Plötz; P H Mook; N J Jansen; S B Oetomo; C R Wildevuur
Related Documents :
6548573 - Intrauterine hypercarbia and lamb lung surfactant synthesis.
1864353 - Application of a new ventilator-multi-plethysmograph system for testing efficacy of sur...
1534363 - Arterial hypertension as a risk factor in the elderly and its treatment.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  ASAIO journal (American Society for Artificial Internal Organs : 1992)     Volume:  43     ISSN:  1058-2916     ISO Abbreviation:  ASAIO J.     Publication Date:    1997 Nov-Dec
Date Detail:
Created Date:  1998-01-15     Completed Date:  1998-01-15     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9204109     Medline TA:  ASAIO J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  916-21     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, University Hospital Groningen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anoxia / blood,  etiology,  therapy
Carbon Dioxide / blood*,  isolation & purification*
Combined Modality Therapy
Disease Models, Animal
Extracorporeal Circulation / methods*
Fluid Therapy
Humans
Infant, Newborn
Lung Injury
Oxygen / blood
Pilot Projects
Pulmonary Surfactants / administration & dosage*
Rabbits
Respiration, Artificial / adverse effects*,  methods*
Respiratory Distress Syndrome, Newborn / therapy
Respiratory Insufficiency / blood,  therapy*
Chemical
Reg. No./Substance:
0/Pulmonary Surfactants; 124-38-9/Carbon Dioxide; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Data acquisition system for dialysis machines. A model for membrane hydraulic permeability.
Next Document:  Heparin clearance profiles after systemic anticoagulation using a heparin removal device system.